Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cotignola
Clinical trial register · Italy

Clinical Trials in Cotignola, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 29 Naples 12 Bergamo 11 Roma 10 Brescia 9
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Padova1 Medtronic1 Ancora Heart, Inc.1
Site location
Milan29 Naples12 Bergamo11 Roma10 Brescia9 Bologna9 Rome7 Florence7 Pavia6 Ancona5 Udine4 Pisa4 Genova4 San Donato Milanese4 Bari4 Ferrara4 Cona3 Turin3 Monza3 Cotignola3 Foggia3 Rozzano3 Lecce3 Taranto3 Verona2 Show all 69
All 69 locations
Target enrolment
to

Trials with a site in Cotignola

3 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
University of Padova
Observational
100
Mercogliano, Brescia, Rho, Monza, Naples, Ragusa, Cotignola, Sassari
2025-06-20
Active, closed
Ancora Heart, Inc.
Not applicable
132
Milan, Cotignola
2019-01-15
Recruiting
Medtronic
Observational
20,000
Ancona, Bari, Bergamo, Bologna, Brescia, Castrovillari, Cotignola, Lecce
1983-01
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-italy/city/cotignola

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies with a site in Cotignola that also match the filters currently applied.

How many clinical trials are recruiting in Cotignola?

2 of the 3 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cotignola), 3 studies
PhaseStudiesRecruitingShare
Observational2266.7%
Not applicable1033.3%

Most active sponsors

Lead sponsors with the most studies (Cotignola)
Lead sponsorStudiesRecruiting
Ancora Heart, Inc.10
Medtronic11
University of Padova11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.